Insulin Analog [EPC]

360683 reported adverse events

Drugs of this class: INSULIN GLARGINE INSULIN ASPART INSULIN LISPRO INSULIN DEGLUDEC INSULIN DETEMIR INSULIN GLARGINE-YFGN (INSULIN DEGLUDEC AND LIRAGLUTIDE) ATTENTION DEFICIT MILD DROPS ATTENTION DEFICIT SEVERE DROPS DNA INSULIN DROPS INSULIN

These side effects are most commonly reported by patients taking drugs of the Insulin Analog [EPC] class:

# Side effect Count
0 BLOOD GLUCOSE INCREASED 68344
1 DRUG INEFFECTIVE 18290
2 BLOOD GLUCOSE DECREASED 17349
3 NAUSEA 15715
4 HYPOGLYCAEMIA 12036
5 FATIGUE 11270
6 DIARRHOEA 10992
7 VISUAL IMPAIRMENT 10971
8 DYSPNOEA 10940
9 MALAISE 10934
See all common reactions for Insulin Analog [EPC]

Drugs of the Insulin Analog [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DEVICE OPERATIONAL ISSUE 1995 0.7977
1 HYPOGLYCAEMIA UNAWARENESS 233 0.7082
2 HYPOGLYCAEMIC UNCONSCIOUSNESS 1184 0.6644
3 HYPOGLYCAEMIC SEIZURE 419 0.5251
4 DIABETIC RETINOPATHY 1399 0.5140
5 SHOCK HYPOGLYCAEMIC 209 0.5036
6 INTERCEPTED PRODUCT SELECTION ERROR 275 0.4669
7 BLOOD GLUCOSE FLUCTUATION 4168 0.4569
8 INSULIN RESISTANCE 695 0.4458
9 BLOOD GLUCOSE INCREASED 68344 0.4362
See all enriched reactions for Insulin Analog [EPC]